1. Home
  2. LEXX vs ASBP Comparison

LEXX vs ASBP Comparison

Compare LEXX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

N/A

Current Price

$4.53

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

N/A

Current Price

$8.83

Market Cap

11.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEXX
ASBP
Founded
2004
2021
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
11.3M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
LEXX
ASBP
Price
$4.53
$8.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 32.2K
24.8K
Earning Date
11-27-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $705,923.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6,915.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 52.05
N/A
52 Week Low
$0.35
$3.31
52 Week High
$21.60
$367.50

Technical Indicators

Market Signals
Indicator
LEXX
ASBP
Relative Strength Index (RSI) 55.94 54.13
Support Level $2.67 $7.65
Resistance Level $10.26 $9.24
Average True Range (ATR) 0.41 0.62
MACD 0.19 0.09
Stochastic Oscillator 74.74 79.10

Price Performance

Historical Comparison
LEXX
ASBP

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About ASBP Aspire Biopharma Holdings Inc.

Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain-agnostic product portfolio that includes mechatronic actuators, human-machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates around 11 manufacturing facilities globally and serves as a tier-one automotive supplier to OEMs and other industrial firms.

Share on Social Networks: